Wells P G, Winn L M
Faculty of Pharmacy, University of Toronto, Ontario, Canada.
Crit Rev Biochem Mol Biol. 1996 Feb;31(1):1-40. doi: 10.3109/10409239609110574.
Although exposure during pregnancy to many drugs and environmental chemicals is known to cause in utero death of the embryo of fetus, or initiate birth defects (teratogenesis) in the surviving offspring, surprisingly, little is known about the underlying biochemical and molecular mechanisms, or the determinants of teratological susceptibility, particularly in humans. In vitro and in vivo studies based primarily on rodent models suggest that many potential embryotoxic xenobiotics are actually proteratogens that must be bioactivated by enzymes such as the cytochromes P450 and peroxidases such as prostaglandin H synthase to teratogenic reactive intermediary metabolites. These reactive intermediates generally are electrophiles or free radicals that bind covalently (irreversibly) to, or directly of indirectly oxidize, embryonic cellular macromolecules such as DNA, protein, and lipid, irreversibly altering cellular function. Target oxidation, known as oxidase stress, often appears to be mediated by reactive oxygen species (ROS) such as hydroxyl radicals. The precise nature of the teratologically relevant molecular targets remains to be established, as do the relative conditions of the various types of macromolecular lesions. Teratological suseptibility appears to be determined in part by a balance among pathways of maternal xenobiotic elimination, embryonic xenobiotic bioactivation and detoxification of the xenobiotic reactive intermediate, direct and indirect pathways for the detoxification of ROS (cytoprotection), and repair of macromolecular lesions. Due largely to immature or otherwise compromised embryonic pathways for detoxification, Cytoprotection, and repair, the embryo is relatively susceptible to reactive intermediates, and teratogenesis via this mechanism can occur from exposure to therapeutic concentrations of drugs, or supposedly safe concentrations of environmental chemicals. Greater insight into the mechanisms involved in human reactive intermediate-mediated teratogenicity, and the determinants of individual teratological susceptibility, will be necessary to reduce the unwarranted embryonic attrition from xenobiotic exposure.
虽然已知孕期接触多种药物和环境化学物质会导致胚胎或胎儿在子宫内死亡,或使存活后代出现出生缺陷(致畸作用),但令人惊讶的是,对于其潜在的生化和分子机制,以及致畸易感性的决定因素,尤其是在人类中的情况,我们知之甚少。主要基于啮齿动物模型的体外和体内研究表明,许多潜在的胚胎毒性异生物实际上是前致畸剂,它们必须通过细胞色素P450等酶以及前列腺素H合酶等过氧化物酶生物活化,才能形成致畸性反应性中间代谢产物。这些反应性中间体通常是亲电试剂或自由基,它们与胚胎细胞大分子如DNA、蛋白质和脂质共价结合(不可逆地),或直接或间接氧化这些大分子,从而不可逆地改变细胞功能。这种靶向氧化,即氧化应激,似乎常常由羟基自由基等活性氧(ROS)介导。致畸相关分子靶点的确切性质以及各种类型大分子损伤的相对情况仍有待确定。致畸易感性似乎部分取决于母体异生物消除途径、胚胎异生物生物活化和异生物反应性中间体解毒途径、ROS解毒(细胞保护)的直接和间接途径以及大分子损伤修复之间的平衡。很大程度上由于胚胎解毒、细胞保护和修复途径不成熟或存在其他缺陷,胚胎对反应性中间体相对敏感,通过这种机制的致畸作用可能因接触治疗浓度的药物或假定安全浓度的环境化学物质而发生。为了减少因异生物暴露导致的不必要的胚胎损失,有必要更深入地了解人类反应性中间体介导的致畸作用机制以及个体致畸易感性的决定因素。